Printer Friendly

COMPANY INFORMATION
Biovail Corporation 7150 Mississauga Rd Mississauga, ON L5N 8M5 Tel: (905) 286-3100 Toll-free: (888) 214-6000 Fax: (905) 286-3050 Contact Name Nelson F. Isabel FP 500 2010 Ranking FP 500 - Sales: 280; Assets: 226; Income: 106 Industry Pharmaceuticals		Key Executives William M. Wells, CEO Margaret J. Mulligan, CFO Develops, manufactures, markets, licenses and distributes pharmaceutical products for the treatment of chronic medical conditions, including specialty and non-specialty central nervous system disorders, cardiovascular disease and pain management. Also generates revenue from third party pharmaceutical companies by promoting and/or co-promoting their products, by providing research development and clinical contract services, and through royalties and/or licensing fees related to the sale of a number of controlled-release products.
FP ADVISOR COVERAGE Biovail Corporation • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • FP Investor Reports • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 936,111 Patheon Inc. 765,812 Cangene Corporation 238,751 Paladin Labs Inc. 109,693 Cardiome Pharma Corp. 54,672 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF SEPT. 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/BVF NYSE/BVF $27.52 $28.47 on Sept. 8/10 $13.60 on Sept. 10/09 US$0.38 US$0.10 1.4% 0.35 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap (000s) 625,937 29.50 US$0.90 June 30/10 107.39% 24.35% 12.96% $4,364,728
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/09 12m Dec. 31/08 12m Dec. 31/07 US$000s US$000s US$000s Operating revenue 820,430 757,178 842,818 Net income 176,455 199,904 195,539 Total assets 2,067,044 1,623,565 1,782,115 US$ US$ US$ Earnings per share* 1.11 1.25 1.22 % % % Return on equity 13.81 16.00 15.04   * Common A Reported in accordance with U.S. GAAP
TRAILING 12-MONTH VALUES Periods ended: June 30/10 June 30/09 US$000s US$000s Operating revenue 911,982 729,439 Net income 144,181 231,910 US$ US$ Earnings per share 0.90 1.47   A Reported in accordance with U.S. GAAP

COMPANY NEWS

Results for 'Biovail Corporation' from past 30 days: No hits. (Links are to articles.)